phenyl acetate has been researched along with Bronchiolitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadi, BL; Antunes, KH; Basso, LA; Bizarro, CV; Cassão, G; Custovic, A; da Silva, EF; de Freitas, DN; de Souza, APD; Dornelles, M; Duarte, L; Epifanio, M; Fachi, JL; Franceschina, C; Gonçalves, JIB; Gonzalez, A; Guima, S; Jones, M; Jorge, TR; Leitão, L; Machado, P; Mansur, DS; Mayer, FQ; Mocellin, M; Oliveira, S; Polack, FP; Pral, LP; Reis, TM; Rigo, M; Rodrigues, H; Setubal, JC; Silveira, J; Sperotto, NDM; Stein, RT; Varela, APM; Vinolo, MAR | 1 |
| Liu, F; Liu, S; Ouyang, J; Sharma, AN; Xiong, W; Xu, R; Yang, B | 1 |
| Chen, XQ; Dong, L; Kong, X; Liao, PY; Wu, JM; Wu, SH; Yin, PL | 1 |
| Li, J; Pan, JH | 1 |
| Azimi, P; Bisgaard, H; Dass, SB; Flores-Nunez, A; Goh, A; Halkas, A; Knorr, BA; Malice, MP; Marchal, JL; Reiss, TF | 1 |
| Amirav, I; Babai, I; Borovitch, Y; Kruger, N; Luder, AS; Mandelberg, A; Miron, D; Tal, G; Zuker, M | 1 |
| Kearns, G; Knorr, B; Maganti, L; Migoya, E; Ramakrishnan, R; Tozzi, CA | 1 |
| Ahmed, T; Kearns, GL; Knorr, B; Li, XS; Lu, S; Maganti, L; Migoya, E; Reiss, TF | 1 |
1 review(s) available for phenyl acetate and Bronchiolitis
| Article | Year |
|---|---|
Leukotriene inhibitors for bronchiolitis in infants and young children.
Topics: Acetates; Bronchiolitis; Cyclopropanes; Humans; Infant; Length of Stay; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2015 |
6 trial(s) available for phenyl acetate and Bronchiolitis
| Article | Year |
|---|---|
Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.
Topics: Acetates; Bronchiolitis; Coinfection; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Leukotriene Antagonists; Male; Pneumonia, Mycoplasma; Prospective Studies; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2016 |
[Clinical efficacy of montelukast for the treatment of bronchiolitis in infants].
Topics: Acetates; Bronchiolitis; Cyclopropanes; Humans; Infant; Leukotriene B4; Leukotriene E4; Quinolines; Sulfides | 2015 |
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
Topics: Acetates; Bronchiolitis; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Severity of Illness Index; Sulfides; Treatment Outcome | 2008 |
A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
Topics: Acetates; Acute Disease; Bronchiolitis; Cross-Over Studies; Cyclopropanes; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Hospitalization; Humans; Infant; Infant, Newborn; Inflammation Mediators; Leukotriene Antagonists; Male; Probability; Prospective Studies; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2008 |
Pharmacokinetics and safety of montelukast in children aged 3 to 6 months.
Topics: Acetates; Anti-Asthmatic Agents; Bronchiolitis; Cyclopropanes; Double-Blind Method; Female; Humans; Infant; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2006 |
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.
Topics: Acetates; Anti-Asthmatic Agents; Area Under Curve; Asthma; Bronchiolitis; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infant; Male; Nonlinear Dynamics; Powders; Quinolines; Sulfides | 2008 |
1 other study(ies) available for phenyl acetate and Bronchiolitis
| Article | Year |
|---|---|
Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis.
Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis; COVID-19; Fatty Acids, Volatile; Humans; Infant; Lung; Mice; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; SARS-CoV-2 | 2022 |